Style | Citing Format |
---|---|
MLA | Navid RB, et al.. "Effect of Delphinium Denudatum Wall. (Jadwar) on Knee Osteoarthritis: A Randomized Double-Blinded Placebo-Controlled Clinical Trial." Pharmaceutical Sciences, vol. 29, no. 3, 2023, pp. 338-345. |
APA | Navid RB, Karimi M, Ghojazadeh M, Bagherzadehkarimi A, Mohammadinasab R, Dolati S, Basnas M, Cheraghi R, Fazljou SMB (2023). Effect of Delphinium Denudatum Wall. (Jadwar) on Knee Osteoarthritis: A Randomized Double-Blinded Placebo-Controlled Clinical Trial. Pharmaceutical Sciences, 29(3), 338-345. |
Chicago | Navid RB, Karimi M, Ghojazadeh M, Bagherzadehkarimi A, Mohammadinasab R, Dolati S, Basnas M, Cheraghi R, Fazljou SMB. "Effect of Delphinium Denudatum Wall. (Jadwar) on Knee Osteoarthritis: A Randomized Double-Blinded Placebo-Controlled Clinical Trial." Pharmaceutical Sciences 29, no. 3 (2023): 338-345. |
Harvard | Navid RB et al. (2023) 'Effect of Delphinium Denudatum Wall. (Jadwar) on Knee Osteoarthritis: A Randomized Double-Blinded Placebo-Controlled Clinical Trial', Pharmaceutical Sciences, 29(3), pp. 338-345. |
Vancouver | Navid RB, Karimi M, Ghojazadeh M, Bagherzadehkarimi A, Mohammadinasab R, Dolati S, et al.. Effect of Delphinium Denudatum Wall. (Jadwar) on Knee Osteoarthritis: A Randomized Double-Blinded Placebo-Controlled Clinical Trial. Pharmaceutical Sciences. 2023;29(3):338-345. |
BibTex | @article{ author = {Navid RB and Karimi M and Ghojazadeh M and Bagherzadehkarimi A and Mohammadinasab R and Dolati S and Basnas M and Cheraghi R and Fazljou SMB}, title = {Effect of Delphinium Denudatum Wall. (Jadwar) on Knee Osteoarthritis: A Randomized Double-Blinded Placebo-Controlled Clinical Trial}, journal = {Pharmaceutical Sciences}, volume = {29}, number = {3}, pages = {338-345}, year = {2023} } |
RIS | TY - JOUR AU - Navid RB AU - Karimi M AU - Ghojazadeh M AU - Bagherzadehkarimi A AU - Mohammadinasab R AU - Dolati S AU - Basnas M AU - Cheraghi R AU - Fazljou SMB TI - Effect of Delphinium Denudatum Wall. (Jadwar) on Knee Osteoarthritis: A Randomized Double-Blinded Placebo-Controlled Clinical Trial JO - Pharmaceutical Sciences VL - 29 IS - 3 SP - 338 EP - 345 PY - 2023 ER - |